1st Circ. Won't Revive Suit Over Vertex Stock Drop
A union retirement fund hasn't plausibly alleged that Vertex Pharmaceuticals acted with a "high degree of recklessness" when it announced promising drug trial results that later turned out to be overstated,...To view the full article, register now.
Already a subscriber? Click here to view full article